FDA Debates Health Risks Of Birth Control Without Prescription

  • The Food and Drug Administration (FDA) may approve birth control pills over-the-counter by the summer, but they expressed hesitation due to concerns over errors in submitted data on the drug’s safety.
  • An advisory committee to the FDA met Tuesday to make a recommendation on whether a historic approval of over-the-counter birth control drugs is safe for consumers. HRA Pharma requested its contraceptive drug, Opill, generically known as norgestrel, to be made available over-the-counter weeks after the Supreme Court overturned Roe v. Wade.
  • However, the agency expressed worries that access to the drug without a prescription may lead to increased errors in usage, according to a public briefing of Tuesday’s meeting.
Click to read full article Go back home

Sign Up for Our Newsletter

Join our list!

Sign up here to get our daily newsletter with the top trending headlines.